OBJECTIVE: A subset of individuals with HIV-associated neurocognitive impairment experience related deficits in "real world" functioning (i.e., independently performing instrumental activities of daily living [IADL]). While performance-based tests of everyday functioning are reasonably sensitive to HIV-associated IADL declines, questions remain regarding the extent to which these tests' highly structured nature fully captures the inherent complexities of daily life. The aim of this study was to assess the predictive and ecological validity of a novel multitasking measure in HIV infection. METHOD: Participants included 60 individuals with HIV infection (HIV+) and 25 demographically comparable seronegative adults (HIV-). Participants were administered a comprehensive neuropsychological battery, questionnaires assessing mood and everyday functioning, and a novel standardized test of multitasking, which involved balancing the demands of four interconnected performance-based functional tasks (i.e., financial management, cooking, medication management, and telephone communication). RESULTS: HIV+ individuals demonstrated significantly worse overall performance, fewer simultaneous task attempts, and increased errors on the multitasking test as compared to the HIV- group. Within the HIV+ sample, multitasking impairments were modestly associated with deficits on standard neuropsychological measures of executive functions, episodic memory, attention/working memory, and information processing speed, providing preliminary evidence for convergent validity. More importantly, multivariate prediction models revealed that multitasking deficits were uniquely predictive of IADL dependence beyond the effects of depression and global neurocognitive impairment, with excellent sensitivity (86%), but modest specificity (57%). CONCLUSIONS: Taken together, these data indicate that multitasking ability may play an important role in successful everyday functioning in HIV+ individuals. PsycINFO Database Record (c) 2011 APA, all rights reserved.
OBJECTIVE: A subset of individuals with HIV-associated neurocognitive impairment experience related deficits in "real world" functioning (i.e., independently performing instrumental activities of daily living [IADL]). While performance-based tests of everyday functioning are reasonably sensitive to HIV-associated IADL declines, questions remain regarding the extent to which these tests' highly structured nature fully captures the inherent complexities of daily life. The aim of this study was to assess the predictive and ecological validity of a novel multitasking measure in HIV infection. METHOD:Participants included 60 individuals with HIV infection (HIV+) and 25 demographically comparable seronegative adults (HIV-). Participants were administered a comprehensive neuropsychological battery, questionnaires assessing mood and everyday functioning, and a novel standardized test of multitasking, which involved balancing the demands of four interconnected performance-based functional tasks (i.e., financial management, cooking, medication management, and telephone communication). RESULTS: HIV+ individuals demonstrated significantly worse overall performance, fewer simultaneous task attempts, and increased errors on the multitasking test as compared to the HIV- group. Within the HIV+ sample, multitasking impairments were modestly associated with deficits on standard neuropsychological measures of executive functions, episodic memory, attention/working memory, and information processing speed, providing preliminary evidence for convergent validity. More importantly, multivariate prediction models revealed that multitasking deficits were uniquely predictive of IADL dependence beyond the effects of depression and global neurocognitive impairment, with excellent sensitivity (86%), but modest specificity (57%). CONCLUSIONS: Taken together, these data indicate that multitasking ability may play an important role in successful everyday functioning in HIV+ individuals. PsycINFO Database Record (c) 2011 APA, all rights reserved.
Authors: Steven Paul Woods; Erin E Morgan; Matthew Dawson; J Cobb Scott; Igor Grant Journal: J Clin Exp Neuropsychol Date: 2006-08 Impact factor: 2.475
Authors: R K Heaton; R A Velin; J A McCutchan; S J Gulevich; J H Atkinson; M R Wallace; H P Godfrey; D A Kirson; I Grant Journal: Psychosom Med Date: 1994 Jan-Feb Impact factor: 4.312
Authors: S Dawes; P Suarez; C Y Casey; M Cherner; T D Marcotte; S Letendre; I Grant; R K Heaton Journal: J Clin Exp Neuropsychol Date: 2008-03-04 Impact factor: 2.475
Authors: Kaitlin B Casaletto; David J Moore; Steven Paul Woods; Anya Umlauf; J C Scott; Robert K Heaton Journal: Clin Neuropsychol Date: 2016-01-12 Impact factor: 3.535
Authors: Raeanne C Moore; Christopher N Kaufmann; Alexandra S Rooney; David J Moore; Lisa T Eyler; Eric Granholm; Steven Paul Woods; Joel Swendsen; Robert K Heaton; J C Scott; Colin A Depp Journal: Am J Geriatr Psychiatry Date: 2016-12-01 Impact factor: 4.105
Authors: Laurel B Smith; Mary Vining Radomski; Leslie Freeman Davidson; Marsha Finkelstein; Margaret M Weightman; Karen L McCulloch; Matthew R Scherer Journal: Am J Occup Ther Date: 2014 Jul-Aug
Authors: Lisa C Obermeit; Jessica Beltran; Kaitlin B Casaletto; Donald R Franklin; Scott Letendre; Ronald Ellis; Christine Fennema-Notestine; Florin Vaida; Ann C Collier; Christina M Marra; David Clifford; Benjamin Gelman; Ned Sacktor; Susan Morgello; David Simpson; J Allen McCutchan; Igor Grant; Robert K Heaton Journal: J Neurovirol Date: 2016-08-24 Impact factor: 2.643
Authors: Marika P Faytell; Katie L Doyle; Sylvie Naar-King; Angulique Y Outlaw; Sharon L Nichols; Kaitlin B Casaletto; Steven Paul Woods Journal: Neuropsychol Rehabil Date: 2015-12-21 Impact factor: 2.868
Authors: J Cobb Scott; Steven Paul Woods; Ofilio Vigil; Robert K Heaton; Igor Grant; Ronald J Ellis; Thomas D Marcotte Journal: J Int Neuropsychol Soc Date: 2011-07 Impact factor: 2.892
Authors: Steven Paul Woods; Jennifer E Iudicello; Erin E Morgan; Marizela V Cameron; Katie L Doyle; Tyler V Smith; Clint Cushman Journal: Arch Clin Neuropsychol Date: 2016-01-06 Impact factor: 2.813
Authors: Ashley M Behrman-Lay; Robert H Paul; Jodi Heaps-Woodruff; Laurie M Baker; Christina Usher; Beau M Ances Journal: J Neurovirol Date: 2015-08-26 Impact factor: 2.643